Deep tech needs owners who can build an industry

A successful laboratory demonstration leaves one difficult question unanswered: can you do it again, at a price someone will pay? Preferably a thousand times. The audience applauds the first device. The customer expects the thousandth to work. Between those expectations lies an industrial business, and a rather substantial demand for capital.

That interval deserves more attention in the debate about deep tech and the space economy. Patents, research teams and prototypes are essential. Their economic significance depends on the organisations that turn them into reliable products. A country can develop remarkable science yet leave the production decisions, customer relationships and commercial value to someone else.

From a private equity perspective, this is where the investment question becomes especially interesting. The asset is no longer just a promising invention. It is the possibility of assembling a company that can deliver, learn and expand without losing the capabilities that made it valuable.

The deep tech funding gap changes as the business develops

Early capital buys an opportunity to test whether an idea works. Later capital must support repeatability, qualification, production and market access. Those are different tasks with different failure modes. Treating them as one continuous technical experiment obscures the point at which management, working capital and commercial discipline become decisive.

Consider a specialist supplier winning a significant space contract. New orders may require equipment, inventory and recruitment before payment arrives. Revenue visibility improves while cash requirements rise. A stronger order book can therefore expose a weak financing structure. Growth has an unfortunate habit of asking to be paid for before it pays back.

Europe’s EIC STEP Scale Up programme addresses the expansion of strategic technologies through investment support for larger funding rounds. Its existence is a useful acknowledgement that scaling requires dedicated capital. It does not make every applicant commercially sound, nor remove the need for a credible operating plan.

For an investor, the practical task is to connect funding to evidence: production yields, delivery performance, customer concentration and achievable margins. A milestone should establish something the next decision-maker can use. Otherwise, each financing round merely buys another presentation explaining why the previous presentation was premature.

Private equity can turn specialist SMEs into industrial platforms

A technically accomplished SME may lack the resources to serve international customers or carry a major development programme. Another company may have the manufacturing organisation it needs. A third may bring market access. The opportunity lies in making those capabilities work together, rather than collecting them under a common letterhead.

This is the serious case for buy-and-build in technology-intensive industries. The acquisition strategy should follow an operating thesis: shared facilities where appropriate, complementary products, better procurement, coordinated customer development. Scale is useful when it improves the business’s ability to fulfil demand. A larger collection of unresolved problems remains a collection of unresolved problems.

Integration requires its own budget and leadership. Knowledge often resides in experienced teams, production routines and relationships that a transaction model cannot fully describe. Retaining that knowledge may matter more than enforcing identical processes across every subsidiary. Standardisation is a tool; applied without judgement, it becomes an expensive administrative hobby.

Financing must leave room for the industrial plan. Debt can support an acquisition, but it cannot perform a qualification test or replace an engineer. Where servicing obligations crowd out essential investment, ownership begins to consume the capability it was supposed to develop. Returns should be tested against realistic spending needs and setbacks, not a frictionless forecast.

Philanthropy can finance the conditions that markets underprovide

Some valuable activities are difficult for a single business to monetise. Independent validation, open safety knowledge and shared testing methods can benefit a whole field. An investor may capture only a small part of their value, even when the wider commercial system depends on them.

Philanthropic funding can make a distinctive contribution here. It can support evidence or access arrangements that would otherwise remain unavailable. The relevant test is whether the intervention changes what becomes possible. Paying for something a commercial operator would have funded anyway offers a weaker case than removing a barrier faced by many organisations.

That distinction also clarifies when philanthropic support should end. Once the obstacle has been overcome, a continuing subsidy may become unnecessary or distort incentives. A successful intervention needs an account of its own eventual redundancy. Institutions rarely put that ambition on the front page, but it deserves a place in the strategy.

Public procurement has a separate function: it can establish credible demand. Grants can support learning. Equity can absorb business risk. Credit can finance suitable cash-flow needs. Effective coordination preserves those differences while ensuring that a capable company can move between instruments without repeatedly losing time, evidence and momentum.

Impact investing must survive the commercial decisions

The GIIN’s core characteristics of impact investing emphasise intention, evidence and active management of outcomes. Technological sophistication is no substitute for that discipline. An advanced product may be commercially attractive without meeting an investor’s particular social or environmental objectives.

Suppose the investment case promises wider access to an essential service. The analysis must identify the intended users, the initial barriers and the mechanism through which the business will remove them. Counting more customers does not establish that previously excluded people have gained access. A growing business and a fulfilled social objective can overlap; the relationship still needs to be demonstrated.

Measurement resources such as IRIS+ can help structure the work. They cannot decide whether a particular result was caused by the investment or would have happened anyway. Nor can a positive indicator cancel unrelated harm. The judgement remains with the people allocating capital.

The real examination comes with expansion. A pricing decision can undermine affordability; a new market can change the user base; an ownership transition can weaken commitments. Impact therefore needs reporting lines, incentives and means of intervention. It should be present when commercial choices are made, not summoned afterwards to improve the annual report’s complexion.

Space investment brings the ownership question into focus

Space capabilities can serve environmental observation, infrastructure management and security. Their dual-use character describes this range of applications. It does not settle the evaluation of any particular use. Investors need to understand customers, deployment conditions and the practical limits of control.

An investment mandate should make those boundaries intelligible. Which applications fit the strategy? Which require additional review? Who can challenge a commercial decision? These are governance questions with economic consequences. Ignoring them leaves policy to whoever happens to be negotiating the next contract.

ESA’s ScaleUp activities support space commercialisation and business growth. They underline the importance of developing companies and markets alongside technologies. Financial engineering alone cannot manufacture a willing customer, however carefully the spreadsheet has been formatted.

For European specialist suppliers, a strong platform can create options: a broader customer base, greater investment capacity, more bargaining power. International partnerships may expand those options. Dependency develops when alternatives disappear. Industrial resilience should therefore be assessed through capabilities and choices, rather than treated as a decorative synonym for size.

In the research I am developing with Leonella Gori for Capital for the Impossible, we bring six elements into the same assessment: capability, use, outcome, governance, capital additionality and scale. The purpose is to improve decisions across different investment mandates. Agreement about evidence need not require agreement about every ethical or commercial preference.

The opportunity for investors is substantial in its ambition, demanding in its execution: help exceptional technical capability become a business that can keep its promises. That requires judgement about customers, people, ownership and consequences. A breakthrough earns the right to be noticed. An industry earns the right to be relied upon.